Senate Bill 579
2021-2022 Regular Session
An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; and establishing the Pharmaceutical Transparency Review Fund.
Co-Sponsorship Memo
Prime Sponsor
Senator Daniel Laughlin
R Senate District 49
Co-Sponsors
Sen. Sharif Street
D Senate District 3
Sen. Timothy Kearney
D Senate District 26
Sen. Christine Tartaglione
D Senate District 2
Sen. Maria Collett
D Senate District 12
Sen. Joe Pittman
R Senate District 41
Sen. Camera Bartolotta
R Senate District 46
Sen. Art Haywood
D Senate District 4
Sen. John Kane
D Senate District 9
Sen. Amanda Cappelletti
D Senate District 17
Sen. Patrick Stefano
R Senate District 32
Sen. Mario Scavello
R Senate District 40
Sen. Kristin Phillips-Hill
R Senate District 28
Sen. Doug Mastriano
R Senate District 33
Sen. Lisa Boscola
D Senate District 18
Sen. Ryan Aument
R Senate District 36
Bill Status & History
Last Action: Referred to Banking & Insurance, April 20, 2021
Senate
S
H
| 0625 | Referred to Banking & Insurance, April 20, 2021 |
Printers Numbers
Votes
There are no votes available.
Committee Meetings
There are no committee meetings available.
Statute References
There are no statute references for this bill.
Senate Bill 579
2021-2022 Regular Session
Sponsors
LAUGHLIN, STREET, KEARNEY, TARTAGLIONE, COLLETT, PITTMAN, BARTOLOTTA, HAYWOOD, KANE, CAPPELLETTI, STEFANO, SCAVELLO, PHILLIPS-HILL, MASTRIANO, BOSCOLA, AUMENT
Short Title
An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; and establishing the Pharmaceutical Transparency Review Fund.
Memo Subject
Pharmaceutical Transparency
Actions
| 0625 | Referred to BANKING AND INSURANCE, April 20, 2021 |
Generated 05/16/2025 11:16 AM